Loading…

Outcome of children and adolescents with central nervous system tumors in phase I trials

Central nervous system (CNS) tumors are a leading cause of death in pediatric oncology. New drugs are desperately needed to improve survival. We evaluated the outcome of children and adolescents with CNS tumors participating in phase I trials within the Innovative Therapies for Children with Cancer...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neuro-oncology 2018-03, Vol.137 (1), p.83-92
Main Authors: Carceller, Fernando, Bautista, Francisco, Jiménez, Irene, Hladun-Álvaro, Raquel, Giraud, Cécile, Bergamaschi, Luca, Dandapani, Madhumita, Aerts, Isabelle, Doz, François, Frappaz, Didier, Casanova, Michela, Morland, Bruce, Hargrave, Darren R., Vassal, Gilles, Pearson, Andrew D. J., Geoerger, Birgit, Moreno, Lucas, Marshall, Lynley V.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Central nervous system (CNS) tumors are a leading cause of death in pediatric oncology. New drugs are desperately needed to improve survival. We evaluated the outcome of children and adolescents with CNS tumors participating in phase I trials within the Innovative Therapies for Children with Cancer (ITCC) consortium. Patients with solid tumors aged 
ISSN:0167-594X
1573-7373
DOI:10.1007/s11060-017-2698-z